The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma

Simon Keane1, Tommy Martinsson2, Per Kogner3

  • 1Translational Medicine, School of Health Sciences, University of Skövde, Skövde, Sweden.

Abstract

Insights

The L27 domain in DLG2-isoform 7/8 is disrupted in aggressive neuroblastoma, impacting cell signaling and viability. Its presence correlates with better prognosis in childhood neural crest tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neuroblastoma is a heterogeneous childhood neural crest tumor.
  • Aggressive forms often exhibit 11q-deletion, leading to reduced DLG2 gene expression.
  • DLG2 isoforms differ by the presence or absence of a L27 domain, crucial for protein complex formation and cell signaling.

Purpose of the Study:

  • To investigate the expression and functional significance of DLG gene family members, specifically DLG1 and DLG2 isoforms with L27 domains, in neuroblastoma.
  • To evaluate the role of DLG2 isoforms and LIN7A in the aggressive 11q-deleted neuroblastoma cell line SKNAS.

Main Methods:

  • Expression analysis of DLG and LIN7 gene families in neuroblastoma using public data and primary tumors.
  • Inclusion of two distinct DLG1 and DLG2 N-terminal transcript isoforms encoding L27 domains.
  • Functional evaluation of DLG2 isoforms and LIN7A in the SKNAS cell line.

Main Results:

  • Only DLG2-isoform 2 and DLG2-isoform 7/8 were expressed in neuroblastoma.
  • Higher expression of L27 domain-containing DLG members correlated with improved survival and prognosis.
  • DLG2-isoform 7/8 expression decreased in high-stage neuroblastoma, and its protein product bound LIN7A, reducing cell proliferation and increasing apoptosis.

Conclusions:

  • DLG2-isoform 7/8 gene expression, but not DLG2-isoform 2, is disrupted in neuroblastoma, especially in aggressive subtypes.
  • The intact L27 domain of DLG2-isoform 7/8 facilitates LIN7A binding, influencing cell polarity, signaling, and cancer cell viability.